Recombinant protein production associated growth inhibition results mainly from transcription and not from translation.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Issue Date
2020-04-06
Metadata
Show full item recordAbstract
Background: Recombinant protein production can be stressful to the host organism. The extent of stress is determined by the specific properties of the recombinant transcript and protein, by the rates of transcription and translation, and by the environmental conditions encountered during the production process. Results: The impact of the transcription of the T7-promoter controlled genes encoding human basic fibroblast growth factor (hFGF-2) and green fluorescent protein (GFP) as well as the translation into the recombinant protein on the growth properties of the production host E. coli BL21(DE3) were investigated. This was done by using expression vectors where the promoter region or the ribosome binding site(s) or both were removed. It is shown that already transcription without protein translation imposes a metabolic burden on the host cell. Translation of the transcript into large amounts of a properly folded protein does not show any effect on cell growth in the best case, e.g. high-level production of GFP in Luria-Bertani medium. However, translation appears to contribute to the metabolic burden if it is connected to protein folding associated problems, e.g. inclusion body formation. Conclusion: The so-called metabolic burden of recombinant protein production is mainly attributed to transcription but can be enhanced through translation and those processes following translation (e.g. protein folding and degradation, heat-shock responses).Citation
Microb Cell Fact. 2020 Apr 6;19(1):83. doi: 10.1186/s12934-020-01343-y.Affiliation
HZI,Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7,38124 Braunschweig, Germany.Publisher
BMC (part of Springer)Journal
Microbial cell factoriesPubMed ID
32252765Type
ArticleLanguage
enEISSN
1475-2859ae974a485f413a2113503eed53cd6c53
10.1186/s12934-020-01343-y
Scopus Count
The following license files are associated with this item:
- Creative Commons
Related articles
- Regulating the T7 RNA polymerase expression in E. coli BL21 (DE3) to provide more host options for recombinant protein production.
- Authors: Du F, Liu YQ, Xu YS, Li ZJ, Wang YZ, Zhang ZX, Sun XM
- Issue date: 2021 Sep 26
- Recombinant protein production-associated metabolic burden reflects anabolic constraints and reveals similarities to a carbon overfeeding response.
- Authors: Li Z, Rinas U
- Issue date: 2021 Jan
- Inclusion body anatomy and functioning of chaperone-mediated in vivo inclusion body disassembly during high-level recombinant protein production in Escherichia coli.
- Authors: Rinas U, Hoffmann F, Betiku E, Estapé D, Marten S
- Issue date: 2007 Jan 1
- Bacteriophage Inspired Growth-Decoupled Recombinant Protein Production in Escherichia coli.
- Authors: Stargardt P, Feuchtenhofer L, Cserjan-Puschmann M, Striedner G, Mairhofer J
- Issue date: 2020 Jun 19
- Evaluation of three industrial Escherichia coli strains in fed-batch cultivations during high-level SOD protein production.
- Authors: Marisch K, Bayer K, Cserjan-Puschmann M, Luchner M, Striedner G
- Issue date: 2013 Jun 11